PubRank
Search
About
Ingmar Blümcke
Author PubWeight™ 78.32
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Brain
2012
2.17
2
Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies.
Epilepsia
2013
2.00
3
Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases.
Brain
2010
1.93
4
Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis.
Ann Neurol
2002
1.61
5
In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy.
J Neurochem
2006
1.48
6
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders.
Expert Opin Investig Drugs
2008
1.36
7
Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo.
J Neurochem
2005
1.35
8
The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.
Epilepsia
2003
1.26
9
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.
Hum Mol Genet
2008
1.26
10
Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.
Cancer
2004
1.23
11
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate.
Hum Mol Genet
2009
1.21
12
The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease.
Stem Cells
2007
1.21
13
Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.
Acta Neuropathol
2013
1.18
14
Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome.
Epilepsia
2002
1.15
15
Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
Acta Neuropathol
2011
1.11
16
Long-term epilepsy-associated tumors.
Brain Pathol
2012
1.10
17
Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy.
J Neuropathol Exp Neurol
2002
1.09
18
Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy.
Eur J Neurosci
2003
1.08
19
The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
Epilepsia
2011
1.07
20
Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy.
J Neuropathol Exp Neurol
2009
1.07
21
Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans.
Brain
2010
1.07
22
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.
Mol Cancer Ther
2006
1.06
23
Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.
J Neurosurg
2005
1.03
24
Functional network integration of embryonic stem cell-derived astrocytes in hippocampal slice cultures.
Development
2003
1.01
25
Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II.
Epilepsia
2008
1.00
26
Focal Cortical Dysplasias: clinical implication of neuropathological classification systems.
Acta Neuropathol
2010
1.00
27
The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.
Mol Cancer Ther
2007
0.99
28
Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
Acta Neuropathol
2010
0.98
29
The emerging role of DNA methylation in epileptogenesis.
Epilepsia
2012
0.95
30
Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain.
Clin Sci (Lond)
2009
0.94
31
Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells.
Brain Pathol
2008
0.94
32
Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies.
Acta Neuropathol
2005
0.94
33
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
J Neuropathol Exp Neurol
2008
0.93
34
EGFR signaling regulates tumor cell migration in craniopharyngiomas.
Clin Cancer Res
2011
0.93
35
Analysis of different types of resection for pediatric patients with temporal lobe epilepsy.
Neurosurgery
2004
0.92
36
Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
Brain Pathol
2008
0.91
37
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.
Brain
2005
0.91
38
Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach.
Am J Surg Pathol
2006
0.91
39
Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation.
Neuroreport
2002
0.91
40
CD34-immunoreactive balloon cells in cortical malformations.
Acta Neuropathol
2004
0.89
41
Molecular neuropathology of epilepsy-associated glioneuronal malformations.
J Neuropathol Exp Neurol
2006
0.88
42
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
Acta Neuropathol
2013
0.87
43
Focal cortical dysplasia type IIb in the rolandic cortex: functional reorganization after early surgery documented by passive task functional MRI.
Epilepsia
2012
0.86
44
Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss.
J Exp Med
2013
0.85
45
MR imaging in the presurgical workup of patients with drug-resistant epilepsy.
AJNR Am J Neuroradiol
2004
0.85
46
Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias.
Epilepsia
2012
0.85
47
Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas.
Acta Neuropathol
2007
0.84
48
Consequences of a novel caveolin-3 mutation in a large German family.
Ann Neurol
2003
0.84
49
Sturge-Weber Syndrome Is Associated with Cortical Dysplasia ILAE Type IIIc and Excessive Hypertrophic Pyramidal Neurons in Brain Resections for Intractable Epilepsy.
Brain Pathol
2014
0.84
50
Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases.
Acta Neuropathol
2006
0.83
51
Intrinsic epileptogenicity of gangliogliomas may be independent from co-occurring focal cortical dysplasia.
Epilepsy Res
2011
0.83
52
The overall pathological status of the left hippocampus determines preoperative verbal memory performance in left mesial temporal lobe epilepsy.
Hippocampus
2013
0.82
53
Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Acta Neuropathol
2006
0.82
54
Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation.
Neurosurgery
2010
0.82
55
Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas.
Acta Neuropathol
2006
0.82
56
Increased frequency of distinct TSC2 allelic variants in focal cortical dysplasias with balloon cells and mineralization.
Neuropathology
2009
0.82
57
White matter angiopathy is common in pediatric patients with intractable focal epilepsies.
Epilepsia
2008
0.82
58
Cellular pathology of amygdala neurons in human temporal lobe epilepsy.
Acta Neuropathol
2003
0.81
59
A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
Virchows Arch
2010
0.81
60
Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.
Am J Pathol
2005
0.81
61
The methylation hypothesis of pharmacoresistance in epilepsy.
Epilepsia
2013
0.81
62
The curse of in silico transformation from Palmini's into the ILAE classification system of focal cortical dysplasia: a critical comment.
Epilepsia
2013
0.80
63
7T MRI features in control human hippocampus and hippocampal sclerosis: an ex vivo study with histologic correlations.
Epilepsia
2014
0.80
64
Axo-somatic inhibition of projection neurons in the lateral nucleus of amygdala in human temporal lobe epilepsy: an ultrastructural study.
Exp Brain Res
2007
0.79
65
MEG in frontal lobe epilepsies: localization and postoperative outcome.
Epilepsia
2011
0.79
66
PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.
PPAR Res
2008
0.79
67
Surgery to treat focal frontal lobe epilepsy in adults.
Neurosurgery
2002
0.78
68
Clinico-pathological investigations of Rasmussen encephalitis suggest multifocal disease progression and associated focal cortical dysplasia.
Epileptic Disord
2013
0.78
69
Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region.
Am J Surg Pathol
2014
0.78
70
Heterotopias, cortical dysplasias and glioneural tumors participate in cognitive processing in patients with temporal lobe epilepsy.
Neurosci Lett
2003
0.78
71
Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Neurosurgery
2004
0.78
72
Drug withdrawal after successful epilepsy surgery: how safe is it?
Epilepsy Behav
2009
0.78
73
Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas.
Acta Neuropathol
2002
0.77
74
Analysis of chromosomal instability in focal cortical dysplasia of Taylor's balloon cell type.
Acta Neuropathol
2004
0.77
75
Genetics of epilepsy: epilepsy research foundation workshop report.
Epileptic Disord
2007
0.77
76
Hypofractionated stereotactic radiotherapy to the rat hippocampus. Determination of dose response and tolerance.
Strahlenther Onkol
2007
0.77
77
Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions.
Acta Neuropathol
2005
0.76
78
Cellular repair strategies in Parkinson's disease.
Ther Adv Neurol Disord
2009
0.76
79
Parry-Romberg syndrome with chronic focal encephalitis: two cases.
Clin Neurol Neurosurg
2010
0.76
80
In response to commentary on cavernoma-related epilepsy: review and recommendations for management-report of the surgical task force of the ILAE commission on therapeutic strategies.
Epilepsia
2014
0.75
81
Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells.
J Neuropathol Exp Neurol
2005
0.75
82
Functional genomics in experimental and human temporal lobe epilepsy: powerful new tools to identify molecular disease mechanisms of hippocampal damage.
Prog Brain Res
2002
0.75
83
Risk reduction in dominant temporal lobe epilepsy surgery combining fMRI/DTI maps, neuronavigation and intraoperative 1.5-Tesla MRI.
Stereotact Funct Neurosurg
2015
0.75
84
Hippocampal dysplasia with balloon cells: case report and discussion on classification.
J Neurol
2014
0.75
85
Neuropathology and epilepsy surgery.
Curr Opin Neurol
2022
0.75
86
Papillary tumor of the pineal region with anaplastic small cell component.
J Neurooncol
2013
0.75